Health gains and financial risk protection afforded by public financing of selected interventions in ethiopia: An extended cost-effectiveness analysis

The Lancet Global Health

Volumn 3, Issue 5, 2015, Pages e288-e296

  Verguet, Stéphane ^a   Olson, Zachary D ^b   Babigumira, Joseph B ^b   Desalegn, Dawit ^c   Johansson, Kjell Arne ^d   Kruk, Margaret E ^a   Levin, Carol E ^b   Nugent, Rachel A ^b   Pecenka, Clint ^e   Shrime, Mark G ^a   Memirie, Solomon Tessema ^d   Watkins, David A ^b   Jamison, Dean T ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c ADDIS ABABA UNIVERSITY   (Ethiopia)

^d UNIVERSITY OF BERGEN   (Norway)

^e PATH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE; PNEUMOCOCCUS VACCINE; ROTAVIRUS VACCINE;

ARTICLE; CESAREAN SECTION; COST EFFECTIVENESS ANALYSIS; DEATH; DIARRHEA; DISEASE CONTROL; ETHIOPIA; HEALTH CARE COST; HEALTH CARE FINANCING; HUMAN; HYPERTENSION; MALARIA; MEASLES; PNEUMOCOCCAL INFECTION; PNEUMONIA; POVERTY; PRIORITY JOURNAL; PUBLIC HEALTH; RISK MANAGEMENT; ROTAVIRUS INFECTION; TUBERCULOSIS; VACCINATION; COST BENEFIT ANALYSIS; COST OF ILLNESS; ECONOMICS; FINANCIAL MANAGEMENT; INFECTION CONTROL; PREVENTION AND CONTROL; QUALITY ADJUSTED LIFE YEAR; STATISTICS AND NUMERICAL DATA;

CESAREAN SECTION; COMMUNICABLE DISEASE CONTROL; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DIARRHEA; ETHIOPIA; FINANCING, GOVERNMENT; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; HYPERTENSION; POVERTY; QUALITY-ADJUSTED LIFE YEARS; VACCINATION;

EID: 84927710502     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(14)70346-8     Document Type: Article

References (70)

1. World Health Report 1999. Making a difference 1999, WHO, World Health Organization, Geneva.
2. World Health Report 2000. Health systems: improving performance 2000, WHO, World Health Organization, Geneva.
3. Roberts MJ, Hsiao W, Berman P, Reich MR Getting health reform right: a guide to improving performance and equity 2004, Oxford University Press, New York.
4. Xu K, Evans DB, Kawabata K, Zeramdini R, Klavus J, Murray CJL Household catastrophic health expenditure: a multicountry analysis. Lancet 2003, 362:111-117.
5. van Doorslaer E, O'Donnell O, Rannan-Eliya RP, et al. Effect of payments for health care on poverty estimates in 11 countries in Asia: an analysis of household survey data. Lancet 2006, 368:1357-1364.
6. Kruk ME, Goldmann E, Galea S Borrowing and selling to pay for health care in low- and middle-income countries. Health Aff 2009, 28:1056-1066.
7. Wagstaff A Measuring financial protection in health. Performance measurement for health system improvement 2010, 114-137. Cambridge University Press, Cambridge. P.C. Smith, E. Mossialos, I. Papanicolas, S. Leatherman (Eds.).
8. World Health Report 2010. Health systems financing: the path to universal coverage 2010, WHO, World Health Organization, Geneva.
9. Jamison DT, Summers LH, Alleyne G, et al. Global health 2035: a world converging within a generation. Lancet 2013, 382:1898. 1855.
10. Yates R Universal health care and the removal of user fees. Lancet 2009, 373:2078-2081.
11. Jamison DT, Breman JG, Measham AR, et al. Disease control priorities in developing countries 2006, Oxford University Press and the World Bank, Washington, DC. 2nd edn.
12. Verguet S, Laxminarayan R, Jamison DT Universal public finance of tuberculosis treatment in India: an extended cost-effectiveness analysis. Health Econ 2015, 24:318-332.
13. Verguet S, Murphy S, Anderson B, Johansson KA, Glass R, Rheingans R Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis. Vaccine 2013, 31:4902-4910.
14. Verguet S, Gauvreau CL, Mishra S, et al. The consequences of tobacco tax on household health and finances in rich and poor smokers in China: an extended cost-effectiveness analysis. Lancet Glob Health 2015, 3:e206-e216.
15. World Health Report 2013. Research for universal health coverage 2013, WHO, World Health Organization, Geneva.
16. World Development Indicators 2013 2013, World Bank, World Bank, Washington, DC.
17. Health Accounts. Global health expenditure database 2012, WHO, World Health Organization, Geneva, (accessed March 20, 2013). http://www.who.int/nha/country/en/index.html.
18. Health Sector Development Program IV 2010/11-2014/15 Federal Democratic Republic of Ethiopia, Ministry of HealthMinistry of Health, (accessed March 20, 2013). http://www.internationalhealthpartnership.net/fileadmin/uploads/ihp/Documents/Country_Pages/Ethiopia/Ethiopia_HSDP_IV_Final_%202010%20-2015.pdf.
19. Banteyerga H Ethiopia's health extension program: improving health through community involvement. MEDICC Rev 2011, 13:46-49.
20. Medhanyie A, Mark S, Kifle Y, et al. The role of health extension workers in improving utilization of maternal health services in rural areas in Ethiopia: a cross sectional study. BMC Health Serv Res 2012, 12:352.
21. 2011 Ethiopia Demographic and Health Survey: key findings 2012, Ethiopia Central Statistical Agency and ICF International, CSA and ICF International, Calverton.
22. Global tuberculosis report 2012 2012, WHO, World Health Organization, Geneva.
23. Zenebe G Characteristics and outcomes of stroke at Tikur Anbessa teaching hospital, Ethiopia. Ethiop Med J 2005, 43:251-259.
24. Bovet P, Gervasoni JP, Mkamba M, Balampama M, Lengeler C, Paccaud F Low utilization of health care services following screening for hypertension in Dar es Salaam (Tanzania): a prospective population-based study. BMC Public Health 2008, 8:407.
25. Elzubier AG Drug compliance among hypertensive patients in Kassala, eastern Sudan. East Mediterr Health J 2000, 6:100-105.
26. WHO STEPwise approach to chronic disease risk factor surveillance, (accessed March 20, 2013). http://www.who.int/chp/steps/ethiopia/en/index.html.
27. Essential Health Services Package for Ethiopia Ethiopia Federal Ministry of Health, (accessed March 20, 2013). http://www.etharc.org/resources/download/finish/33/80.
28. Department of Economic and Social Affairs. World population prospects: the 2010 revision 2011, United Nations Population Division, United Nations, New York.
29. Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012, 379:2151-2161.
30. Walker CLF, Rudan I, Liu L, et al. Global burden of childhood pneumonia and diarrhoea. Lancet 2013, 381:1405-1416.
31. Madhi SA, Cunliffe NA, Steele D, et al. Effect of rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010, 362:289-298.
32. Griffiths UK, Korczak VS, Ayalew D, Yigzaw A Incremental system costs of introducing combined DTwP-hepatitis B-Hib vaccine into national immunization services in Ethiopia. Vaccine 2009, 27:1426-1432.
33. Stack ML, Ozawa S, Bishai DM, et al. Estimated economic benefits during the 'decade of vaccines' include treatment savings, gains in labor productivity. Health Aff 2011, 30:1021-1028.
34. Country specific unit costs 2005, WHO, World Health Organization, Geneva, (accessed March 20, 2013). http://www.who.int/choice/costs/en.
35. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003, 9:565-572.
36. O'Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009, 374:893-902.
37. Rudan I, Tomaskovic L, Boschi-Pinto C, et al. Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull World Health Organ 2004, 82:895-903.
38. Tasslimi A, Nakamura MM, Levine O, Knoll MD, Russell LB, Sinha A Cost effectiveness of child pneumococcal conjugate vaccination in GAVI-eligible countries. Int Health 2011, 3:259-269.
39. Theodoratou E, Johnson S, Jhass A, et al. The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality. Int J Epidemiol 2010, 39:i172-i185.
40. Bishai D, Johns B, Nair D, et al. The cost-effectiveness of supplementary immunization activities for measles: a stochastic model for Uganda. J Infect Dis 2011, 204:S107-S115.
41. Sudfeld CR, Navar AM, Halsey NA Effectiveness of measles vaccination and vitamin A treatment. Int J Epidemiol 2010, 39:i48-i55.
42. Wolfson LJ, Grais RF, Luquero FJ, Birmingham ME, Strebel PM Estimates of measles case fatality ratios: a comprehensive review of community-based studies. Int J Epidemiol 2009, 38:192-205.
43. Munos MK, Walker CLF, Black RE The effect of oral rehydration solution and recommended home fluids on diarrhea mortality. Int J Epidemiol 2010, 39:i75-i87.
44. Lamberti LM, Walker CL, Black RE Systematic review of diarrhea duration and severity in children and adults in low- and middle-income countries. BMC Public Health 2012, 12:276.
45. Robberstad B, Strand T, Black RE, Sommerfelt H Cost-effectiveness of zinc as adjunct therapy for acute childhood diarrhea in developing countries. Bull World Health Organ 2004, 82:523-531.
46. Theodoratou E, Al-Jilaihawi S, Woodward F, et al. The effect of case management on childhood pneumonia mortality in developing countries. Int J Epidemiol 2010, 39:i155-i171.
47. Ajayi IO, Browne EN, Bateganya F, et al. Effectiveness of artemisnin-based combination therapy used in the context of home management of malaria: a report from three study sites in sub-Saharan Africa. Malar J 2008, 7:190.
48. Malaria in Ethiopia UNICEF, (accessed April 2, 2013). http://www.unicef.org/ethiopia/ET_Media_Malaria_backgrounder_07.pdf.
49. Lubell Y, Staedke SG, Greewood BM, et al. Likely health outcomes for untreated acute febrile illness in the tropics in decision and economic models; a Delphi survey. PLoS One 2011, 6:e17439.
50. Gessessew A, Barnabas G, Prata N, Weidert K Task shifting and sharing in Tigray, Ethiopia, to achieve comprehensive emergency obstetric care. Int J Gynaecol Obstet 2011, 113:28-31.
51. Admasu K, Haile-Mariam A, Bailey P Indicators for availability, utilization, and quality of emergency obstetric care in Ethiopia, 2008. Int J Gynaecol Obstet 2011, 115:101-105.
52. Neilson JP, Lavender T, Quenby S, Wray S Obstructed labour. Br Med Bull 2003, 67:191-204.
53. Ali Y Analysis of caesarean delivery in Jimma Hospital, south-western Ethiopia. East Afr Med J 1995, 72:60-63.
54. Kifle Y, Nigatu T Cost-effectiveness analysis of clinical specialist outreach as compared to referral system in Ethiopia: an economic evaluation. Cost Eff Resour Alloc 2010, 8:13.
55. Vlassoff M, Shearer J, Walker D, Lucas H Economic impact of unsafe abortion-related morbidity and mortality: evidence and estimation challenges. Institute of Development Studies at the University of Sussex, research report 59 2008, University of Sussex, Brighton.
56. Global tuberculosis control: surveillance, planning, financing 2008, WHO, World Health Organization, Geneva.
57. Datiko DG, Lindtjørn B Cost and cost-effectiveness of treating smear-positive tuberculosis by health extension workers in Ethiopia: an ancillary cost-effectiveness analysis of community randomized trial. PLoS One 2010, 5:e9158.
58. International drug price indicator guide 2011, MSH/WHO, Management Sciences for Health/World Health Organization, Geneva.
59. Murray CJL, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013, 380:2197-2223.
60. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903-1913.
61. Ethiopia's progress towards eradicating poverty: an interim report on poverty analysis study (2010/2011) Ethiopia Ministry of Finance and Economic Development, (accessed March 20, 2013). http://www.mofed.gov.et/English/Resources/Documents/Interim%20Report%20on%202010-11%20Poverty%20Analysis.pdf.
62. Ethiopia's Health Extension Platform: a background paper prepared for the HEPCAP1 project. Ethiopia HEPCAPS1 series paper #1 2012, HEPCAPS1 Project Team, Harvard School of Public Health and Yale Global Health Leadership Institute, Boston, MA, and New Haven, CT.
63. Lagomarsino G, Garabrant A, Adyas A, Muga R, Otoo N Moving towards universal health coverage: health insurance reforms in nine developing countries in Africa and Asia. Lancet 2012, 380:933-943.
64. Saksena P, Antunes AF, Xu K, Musango L, Carrin G Mutual health insurance in Rwanda: evidence on access to care and financial risk protection. Health Policy 2011, 99:203-209.
65. Atun R, Aydin S, Chakraborty S, et al. Universal health coverage in Turkey: enhancement of equity. Lancet 2013, 382:65-99.
66. Vapattanawong P, Hogan MC, Hanvoravongchai P, et al. Reductions in child mortality levels and inequalities in Thailand: analysis of two censuses. Lancet 2007, 369:850-855.
67. Making fair choices on the path to universal health coverage. Final report of the WHO Consultative Group on Equity and Universal Health Coverage 2014, WHO, World Health Organization, Geneva.
68. Norheim OF, Baltussen R, Johri M, et al. Guidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysis. Cost Eff Resour Alloc 2014, 12:18.
69. Murray CJL, Evans DB, Acharya A, Baltussen R Development of WHO guidelines on generalized cost-effectiveness analysis. Health Econ 2000, 9:235-251.
70. Drislane FW, Akpalu A, Wegdam HHJ The medical system in Ghana. Yale J Biol Med 2014, 87:321-326.